Reduced GLUT4 expression and elevated ERK and IGF-1 in CRC patients with MetS correlated with CRC clinical characteristics (e.g., size, distant metastases and more advanced tumor stage) [32]. Here, IGF1 is linked to colorectal carcinoma.